Gilead Sciences (GILD) Exchange Rate Effect (2009 - 2026)

Gilead Sciences (GILD) reported Exchange Rate Effect of -$11.0 million for Q1 2026, down 157.89% on a YoY basis from $19.0 million in Q1 2025, and down 320.0% quarter-over-quarter from $5.0 million in Q4 2025.

Gilead Sciences (GILD) Exchange Rate Effect (2009 - 2026) Analysis & Trends

Gilead Sciences has reported Exchange Rate Effect for 18 years, with the latest figure at -$11.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Exchange Rate Effect fell 157.89% year-over-year to -$11.0 million; the trailing twelve-month figure through Mar 2026 stood at $62.0 million (up 2166.67% YoY), and the FY2025 full-year result was $92.0 million, up 330.0% from the prior year.
  • Exchange Rate Effect for Q1 2026 stood at -$11.0 million, down from $5.0 million in the prior quarter.
  • The five-year high for Exchange Rate Effect was $75.0 million in Q4 2022, with the low at -$72.0 million in Q3 2022.
  • Historically, Exchange Rate Effect has averaged $2.1 million across 5 years, with a median of -$5.0 million in 2025.
  • The largest YoY upside for Exchange Rate Effect was 933.33% in 2022 against a maximum downside of 340.0% in 2022.
  • Gilead Sciences' Exchange Rate Effect stood at $75.0 million in 2022, then sank by 50.67% to $37.0 million in 2023, then tumbled by 248.65% to -$55.0 million in 2024, then jumped by 109.09% to $5.0 million in 2025, then sank by 320.0% to -$11.0 million in 2026.
  • The last three Exchange Rate Effect figures came in at -$11.0 million (Q1 2026), $5.0 million (Q4 2025), and -$5.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 2.70 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 67.00 Mn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn -25.00 Mn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn -12.00 Mn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -19.00 Mn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn -11.00 Mn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 19.00 Mn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -48.00 Mn
10 Novartis Ag 108.28 Bn 107.60 Bn - -77.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.00 Mn
Mar 31, 2026 -11.00 Mn
Dec 31, 2025 5.00 Mn
Dec 31, 2025 5.00 Mn
Sep 30, 2025 -5.00 Mn
Sep 30, 2025 -5.00 Mn
Jun 30, 2025 73.00 Mn
Jun 30, 2025 73.00 Mn
Mar 31, 2025 19.00 Mn
Mar 31, 2025 19.00 Mn
Dec 31, 2024 -55.00 Mn
Dec 31, 2024 -55.00 Mn
Sep 30, 2024 44.00 Mn
Sep 30, 2024 44.00 Mn
Jun 30, 2024 -11.00 Mn
Jun 30, 2024 -11.00 Mn
Mar 31, 2024 -18.00 Mn
Mar 31, 2024 -18.00 Mn
Dec 31, 2023 37.00 Mn
Dec 31, 2023 37.00 Mn